Fenghui Yixue
Independent innovators in clinical biochemical reagents offering comprehensive solutions from research and development to production and quality inspection
Independent innovators in clinical biochemical reagents offering comprehensive solutions from research and development to production and quality inspection
Fenghui Yixue is an innovative company specializing in the independent development of clinical biochemical reagents. Founded in 1997, the company is dedicated to providing comprehensive solutions, from research and development to production and quality inspection. Its focus lies in biotechnology and health care, with a keen emphasis on producing medical devices. The company is structured into several functional divisions, including a marketing company, a research and development department, a production department, and a quality inspection department. The latest investment in Fenghui Yixue came in the form of a CNY13.50M Post-IPO equity investment on 05 May 2016. This round saw the participation of investment firms DJ Capital and Ch-gemstone capital. The company's slogan, "Independent innovators in clinical biochemical reagents," encapsulates its mission to provide advanced solutions in the clinical and healthcare sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | CNY13.50M | 2 |
|
05 May 2016 |
| Angel Round | CNY3.00M | 3 |
|
15 Nov 2010 |
No recent news or press coverage available for Fenghui Yixue.
We care about your data, and we'd love to use cookies make your experience better.